Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study

BACKGROUND: Medulloblastoma is extremely rare in adults. The role of chemotherapy for average-risk adult patients remains controversial. Surgery and radiotherapy provide a significant disease control and a good prognosis, but about 25% of average-risk patients have a relapse and die because of disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Franceschi, E., Minichillo, S., Mura, A., Tosoni, A., Mascarin, M., Tomasello, C., Bartolini, S., Brandes, A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425050/
https://www.ncbi.nlm.nih.gov/pubmed/32787805
http://dx.doi.org/10.1186/s12885-020-07237-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425050/
https://www.ncbi.nlm.nih.gov/pubmed/32787805
http://dx.doi.org/10.1186/s12885-020-07237-x

Ejemplares similares